These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 32052264

  • 1. Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study.
    Baba M, Kuroha M, Ohwada S, Murayama E, Matsui N.
    Pain Ther; 2020 Jun; 9(1):261-278. PubMed ID: 32052264
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia.
    Ushida T, Katayama Y, Hiasa Y, Nishihara M, Tajima F, Katoh S, Tanaka H, Maeda T, Furusawa K, Richardson M, Kakehi Y, Kikumori K, Kuroha M.
    Neurology; 2023 Mar 14; 100(11):e1193-e1206. PubMed ID: 36517235
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study.
    Merante D, Rosenstock J, Sharma U, Feins K, Hsu C, Vinik A, DS-5565-A-U201 US Phase 2 Study Investigators.
    Pain Med; 2017 Nov 01; 18(11):2198-2207. PubMed ID: 28371941
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term safety and efficacy of mirogabalin in Asian patients with diabetic peripheral neuropathic pain.
    Baba M, Matsui N, Kuroha M, Wasaki Y, Ohwada S.
    J Diabetes Investig; 2020 May 01; 11(3):693-698. PubMed ID: 31722446
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mirogabalin in Japanese Patients with Renal Impairment and Pain Associated with Diabetic Peripheral Neuropathy or Post-Herpetic Neuralgia: A Phase III, Open-Label, 14-Week Study.
    Baba M, Takatsuna H, Matsui N, Ohwada S.
    J Pain Res; 2020 May 01; 13():1811-1821. PubMed ID: 32765056
    [Abstract] [Full Text] [Related]

  • 11. Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia: Results from an open-label extension of a multicenter randomized, double-blind, placebo-controlled trial.
    Kato J, Matsui N, Kakehi Y, Murayama E, Ohwada S.
    Medicine (Baltimore); 2020 Sep 04; 99(36):e21976. PubMed ID: 32899037
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.
    Rosenstock J, Tuchman M, LaMoreaux L, Sharma U.
    Pain; 2004 Aug 04; 110(3):628-638. PubMed ID: 15288403
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study.
    Arnold LM, Whitaker S, Hsu C, Jacobs D, Merante D.
    Curr Med Res Opin; 2019 Oct 04; 35(10):1825-1835. PubMed ID: 31284771
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y, Ding X, Cheng Y, Fan D, Tan L, Wang Y, Zhao Z, Hong Z, Zhou D, Pan X, Chen S, Martin A, Tang H, Cui L.
    Clin Ther; 2011 Feb 04; 33(2):159-66. PubMed ID: 21444113
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE, Lee DI, Lee SC, Song SO, Yoon DM, Yoon MH, Kim HK, Lee YW, Kim C, Lee PB.
    Clin Ther; 2010 Dec 04; 32(14):2370-85. PubMed ID: 21353106
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Switching From Pregabalin to Mirogabalin in Patients with Peripheral Neuropathic Pain: A Multi-Center, Prospective, Single-Arm, Open-Label Study (MIROP Study).
    Kimura Y, Yamaguchi S, Suzuki T, Kato J, Chiba S, Hirakawa N, Yamaguchi K, Tanabe Y, Takatsuna H, Kenyoshi Y, Shiosakai K, Sakai M, Iseki M.
    Pain Ther; 2021 Jun 04; 10(1):711-727. PubMed ID: 33856660
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.